Sleep disturbances, psychiatric disorders, and psychotropic drugs.
Brain neurotransmitter dysfunctions involved in the pathophysiological processes of psychiatric disorders are likely to be reflected by concomitant alterations in sleep continuity and architecture. Since the corrective effects of psychotropic drugs on dysfunctional neurotransmission systems can be evidenced through polysomnographic recordings, one may consider sleep as a kind of "window" on the neurobiology of psychiatric disorders. During the last 10 years, major breakthroughs in our understanding of sleep-wake mechanisms have provided some indications on how psychotropic drugs could influence the sleep-wake cycle. In this review, recent inroads into the understanding of sleep regulatory neural mechanisms are introduced and discussed in terms of the effects of psychotropic drugs. The relationship between the pathophysiological process of a disease, its consequence on sleep, and the corrective effect of a psychotropic drug are exemplified by two psychopathological states: substance withdrawal and major depression. One may conclude that polysomnographic recordings are a unique noninvasive tool to analyze brain functioning, and are particularly well suited to evaluating the objective effects of new psychotropic drugs.
Staner
Luc
L
Sleep Laboratory, Forenap, Centre Hospitalier de Rouffach, Rouffach, France. luc.staner@forenap.asso.fr
D000818:Animals; D001921:Brain / Q000033:anatomy & histology / Q000503:physiopathology; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D008959:Models, Neurological; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012894:Sleep Stages / Q000187:drug effects / Q000502:physiology; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000209:etiology
D011619:Psychotropic Drugs